Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Kiniksa Pharmaceuticals, Ltd. | StockGist | StockGist

Companies
KNSA
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings KNSASCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Kiniksa Pharmaceuticals, Ltd.

Filed Mar 6, 2026

Accepted Mar 6, 2026, 10:05 AM ET

CIK 0001730430

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

315,066

Reporting Person

Kiniksa Pharmaceuticals International, plc

Person Type

HC

Amendment History

9 filings

SCHEDULE 13G
Original
Viewing
Mar 6, 20260000315066-26-000640
SCHEDULE 13G/A
Amendment 1
Feb 14, 20250001104659-25-014002
SCHEDULE 13G/A
Amendment 2
Apr 23, 20250002052113-25-001430
SCHEDULE 13G/A
Amendment 3
May 14, 20250001104659-25-048493
SCHEDULE 13G/A
Amendment 4
Jul 9, 20250001104659-25-066696
SCHEDULE 13G/A
Amendment 5
Jul 17, 20250002052113-25-002968
SCHEDULE 13G/A
Amendment 6
Oct 31, 20250000102909-25-000265
SCHEDULE 13G/A
Amendment 7
Feb 13, 20260001104659-26-015194
SCHEDULE 13G/A
Amendment 8
Latest
Mar 27, 20260000102909-26-001633

Key Facts

Shares Owned

315,066

Recent Filings

Kiniksa Pharmaceuticals, Ltd.1 weeks ago

Kiniksa Pharmaceuticals, Ltd.1 months ago

Kiniksa Pharmaceuticals, Ltd.1 months ago

Kiniksa Pharmaceuticals, Ltd.1 months ago

Kiniksa Pharmaceuticals, Ltd.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice